Bristol-Myers Squibb Co (BMY)
51.59
-0.75
(-1.43%)
USD |
NYSE |
Mar 18, 16:00
52.00
+0.41
(+0.79%)
Pre-Market: 05:31
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 104.32B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -19.41% |
Valuation | |
PE Ratio | 13.37 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 2.382 |
Price to Book Value | 3.545 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.60 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 1.351 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 39.24% |
Profile
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group. |
URL | https://www.bms.com |
Investor Relations URL | https://www.bms.com/investors.html |
HQ State/Province | New Jersey |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Equity Style | Large Cap/Value |
Next Earnings Release | Apr. 25, 2024 |
Last Earnings Release | Feb. 02, 2024 |
Next Ex-Dividend Date | Apr. 04, 2024 |
Last Ex-Dividend Date | Jan. 04, 2024 |
Ratings
Profile
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group. |
URL | https://www.bms.com |
Investor Relations URL | https://www.bms.com/investors.html |
HQ State/Province | New Jersey |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Equity Style | Large Cap/Value |
Next Earnings Release | Apr. 25, 2024 |
Last Earnings Release | Feb. 02, 2024 |
Next Ex-Dividend Date | Apr. 04, 2024 |
Last Ex-Dividend Date | Jan. 04, 2024 |